These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8561609)

  • 1. Thromboembolism and bleeding: clinical strategies.
    Copeland JG
    Ann Thorac Surg; 1996 Jan; 61(1):376-7; discussion 378-9. PubMed ID: 8561609
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulation management in patients undergoing mechanical circulatory support.
    Görlinger K; Bergmann L; Dirkmann D
    Best Pract Res Clin Anaesthesiol; 2012 Jun; 26(2):179-98. PubMed ID: 22910089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term management of an implantable left ventricular assist device using low molecular weight heparin and antiplatelet therapy: a possible alternative to oral anticoagulants.
    Meuris B; Arnout J; Vlasselaers D; Schetz M; Meyns B
    Artif Organs; 2007 May; 31(5):402-5. PubMed ID: 17470211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and treatment of major blood loss.
    Szabo S; Oikonomopoulos T; Hoffmeister HM
    N Engl J Med; 2007 Sep; 357(12):1260; author reply 1261. PubMed ID: 17881761
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oral anticoagulants and antiaggregants in heart valve prostheses].
    Dettori AG; Manotti C
    G Ital Cardiol; 1990 Aug; 20(8):758-65. PubMed ID: 2272425
    [No Abstract]   [Full Text] [Related]  

  • 6. Usefulness of anti-platelet therapy testing in children supported with a ventricular assist device.
    May LJ; Liu X; Tesoro T; Yang J; Lo C; Chen S; Murray J; Rosenthal DN; Massicotte P; Michelson AD; Almond CS
    J Heart Lung Transplant; 2019 Jul; 38(7):781-783. PubMed ID: 31006520
    [No Abstract]   [Full Text] [Related]  

  • 7. [Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
    Prisco D
    Haematologica; 2001 Sep; 86(9 Suppl):12-3. PubMed ID: 11759618
    [No Abstract]   [Full Text] [Related]  

  • 8. [What anticoagulant therapy should be used for what form of atrial fibrillation?].
    Frantz E
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S10-1. PubMed ID: 10818997
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of thromboembolism in non-rheumatic atrial fibrillation: an update].
    Pengo V; De Caterina R
    Ital Heart J Suppl; 2001 Sep; 2(9):972-9. PubMed ID: 11675834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of anticoagulants, antiplatelet agents, and the combination in patients with mechanical heart valves.
    Bussey HI
    J Heart Valve Dis; 2004 May; 13(3):319-24. PubMed ID: 15222274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis.
    Ruiz-Nodar JM; Marín F; Hurtado JA; Valencia J; Pinar E; Pineda J; Gimeno JR; Sogorb F; Valdés M; Lip GY
    J Am Coll Cardiol; 2008 Feb; 51(8):818-25. PubMed ID: 18294566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II).
    Klovaite J; Gustafsson F; Mortensen SA; Sander K; Nielsen LB
    J Am Coll Cardiol; 2009 Jun; 53(23):2162-7. PubMed ID: 19497443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events in the use of HeartMate vented electric and Novacor left ventricular assist devices: comparing apples and oranges.
    Pasque MK; Rogers JG
    J Thorac Cardiovasc Surg; 2002 Dec; 124(6):1063-7. PubMed ID: 12447167
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antithrombotic agents].
    Azougagh Oualane F; Doutremepuich C; Doutremepuich F
    Ann Cardiol Angeiol (Paris); 1993 Sep; 42(7):385-92. PubMed ID: 8285566
    [No Abstract]   [Full Text] [Related]  

  • 16. Aspirin for atrial fibrillation.
    Douglas M; Strelnick A
    J Fam Pract; 2000 Jan; 49(1):7-8. PubMed ID: 10678329
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessing Anticoagulation Practice Patterns in Patients on Durable Mechanical Circulatory Support Devices: An International Survey.
    Jennings DL; Horn ET; Lyster H; Panos AL; Teuteberg JJ; Lehmkuhl HB; Perez A; Shullo MA
    ASAIO J; 2016; 62(1):28-32. PubMed ID: 26309097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dental extractions in patients taking anticoagulants: is alteration of the anticoagulant regime necessary?].
    Madrid C
    Rev Med Suisse; 2005 May; 1(21):1418, 1421-2, 1424. PubMed ID: 15997980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
    Själander A; Wallentin L; Rosenqvist M; Svensson P
    Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
    [No Abstract]   [Full Text] [Related]  

  • 20. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
    Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
    Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.